Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer.

Dubaere E, Goffaux M, Wanet M, Bihin B, Gheldof C, Demoulin AS, Bolly A, Bustin F, Duplaquet F, Baugnee PE, Gustin M, Hers V, Maisin F, Marchand E, Ocak S, Pirard L, Vancutsem O, Van Neck E, Vandermoten G, Zaharia L, Remouchamps V.

BMC Cancer. 2019 Jun 28;19(1):639. doi: 10.1186/s12885-019-5863-2.

2.

A Multicenter Study to Assess EGFR Mutational Status in Plasma: Focus on an Optimized Workflow for Liquid Biopsy in a Clinical Setting.

Sorber L, Zwaenepoel K, De Winne K, Van Casteren K, Augustus E, Jacobs J, Zhang XH, Galdermans D, De Droogh E, Lefebure A, Morel AM, Saenen E, Bustin F, Demedts I, Himpe U, Pieters T, Germonpré P, Derijcke S, Deschepper K, Van Meerbeeck JP, Rolfo C, Pauwels P.

Cancers (Basel). 2018 Aug 27;10(9). pii: E290. doi: 10.3390/cancers10090290.

3.

[Mediastinitis following EBUS : about a complication after a minimally invasive investigation].

Renson A, Delobbe A, Bustin F.

Rev Med Liege. 2018 Jul;73(7-8):387-393. French.

4.

Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer.

Ignatiadis M, Zardavas D, Lemort M, Wilke C, Vanderbeeken MC, D'Hondt V, De Azambuja E, Gombos A, Lebrun F, Dal Lago L, Bustin F, Maetens M, Ameye L, Veys I, Michiels S, Paesmans M, Larsimont D, Sotiriou C, Nogaret JM, Piccart M, Awada A.

PLoS One. 2016 Jul 25;11(7):e0154009. doi: 10.1371/journal.pone.0154009. eCollection 2016.

5.

Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non-small cell lung cancer.

Doebele RC, Spigel D, Tehfe M, Thomas S, Reck M, Verma S, Eakle J, Bustin F, Goldschmidt J Jr, Cao D, Alexandris E, Yurasov S, Camidge DR, Bonomi P.

Cancer. 2015 Mar 15;121(6):883-92. doi: 10.1002/cncr.29132. Epub 2014 Nov 6.

6.

Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III study.

Gridelli C, de Marinis F, Thomas M, Prabhash K, El Kouri C, Blackhall F, Bustin F, Pujol JL, John WJ, San Antonio B, Zimmermann A, Chouaki N, Visseren-Grul C, Paz-Ares LG.

J Thorac Oncol. 2014 Jul;9(7):991-7. doi: 10.1097/JTO.0000000000000207.

7.

Survival outcomes in patients with advanced non-small cell lung cancer treated with erlotinib: expanded access programme data from Belgium (the TRUST study).

Van Meerbeeck J, Galdermans D, Bustin F, De Vos L, Lechat I, Abraham I.

Eur J Cancer Care (Engl). 2014 May;23(3):370-9. doi: 10.1111/ecc.12146. Epub 2013 Oct 24.

PMID:
24152297
8.

Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer - EORTC 08062.

O'Brien ME, Konopa K, Lorigan P, Bosquee L, Marshall E, Bustin F, Margerit S, Fink C, Stigt JA, Dingemans AM, Hasan B, Van Meerbeeck J, Baas P.

Eur J Cancer. 2011 Oct;47(15):2322-30. doi: 10.1016/j.ejca.2011.05.020. Epub 2011 Jun 16.

PMID:
21684151
9.

Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial.

Herbst RS, Ansari R, Bustin F, Flynn P, Hart L, Otterson GA, Vlahovic G, Soh CH, O'Connor P, Hainsworth J.

Lancet. 2011 May 28;377(9780):1846-54. doi: 10.1016/S0140-6736(11)60545-X.

10.

[Catamenial pneumothorax : a case report].

Kolan C, Massin Y, Giner C, Broux R, Emonts P, Bustin F.

Rev Med Liege. 2007 Jul-Aug;62(7-8):487-91. French.

11.

[Diabetes insipidus in a patient with small-cell lung cancer: a paradox?].

Schleich F, Bustin F, Bosquee L, Legros JJ.

Ann Endocrinol (Paris). 2005 Sep;66(4):355-60. French.

PMID:
16392186
12.

[Clinical case of the month. A recurrent chylothorax in Bourneville tuberous sclerosis].

Bustin F, Gustin M, Robin M, Cambier P, Warling X, Chantraine JM.

Rev Med Liege. 2002 Aug;57(8):493-6. French.

13.

[The clinical case of the month. Apropos of a case of unexplained fever].

Bustin F, Kolh P, Creemers E, Fraipont V, Demonty J, Limet R.

Rev Med Liege. 1998 Jan;53(1):7-10. French.

PMID:
9555174
14.

[Energy expenditure in man].

Bustin F, Pestieau SR, Paquot N, Scheen AJ, Lefèbvre PJ.

Rev Med Liege. 1997 Feb;52(2):101-4. French. No abstract available.

PMID:
9173475

Supplemental Content

Loading ...
Support Center